Serum estradiol should be monitored not only during the peri-menopausal period but also the post-menopausal period at the time of aromatase inhibitor administration

Taeko Nagao(Tokushima University), Mitsunori Sasa(Tokushima Breast Care Clinic), Hitoshi Zembutsu, Akira Tangoku, Yusuke Nakamura(Rissho University), Toshiyuki Hirose(Tokushima Hospital), Junko Honda(Tokushima Hospital), Masako Takahashi(Tokushima Breast Care Clinic), Misako Kira(Tokushima University)
World Journal of Surgical Oncology
November 12, 2009
Cited by 14


Related Papers